Mohit Bansal
Stock Analyst at Wells Fargo
(4.77)
# 593
Out of 4,673 analysts
800
Total ratings
62.1%
Success rate
12.3%
Average return
Main Sectors:
Stocks Rated by Mohit Bansal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTX BioNTech SE | Maintained: Buy | $140 | $113.12 | +23.76% | 13 | Aug 20, 2026 | |
| MRK Merck & Co. | Rated: Buy | $150 | $152.20 | -1.45% | 55 | Aug 19, 2026 | |
| ABBV AbbVie | Rated: Buy | $295 → $300 | $265.97 | +12.79% | 43 | Aug 17, 2026 | |
| MIST Milestone Pharmaceuticals | Maintained: Buy | $7 | $1.08 | +548.15% | 5 | Aug 13, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $750 | $840.84 | -10.80% | 68 | Aug 12, 2026 | |
| VERA Vera Therapeutics | Rated: Buy | $70 | $32.28 | +116.89% | 11 | Aug 12, 2026 | |
| MLYS Mineralys Therapeutics | Maintained: Buy | $55 | $26.95 | +104.08% | 16 | Aug 12, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $300 | $252.16 | +18.97% | 20 | Aug 10, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $75 → $80 | $69.33 | +15.39% | 26 | Aug 7, 2026 | |
| HALO Halozyme Therapeutics | Rated: Hold | $75 → $95 | $107.62 | -11.73% | 27 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 → $80 | $65.96 | +21.29% | 23 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,280 → $1,330 | $1,280.34 | +3.88% | 68 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 | $147.60 | +11.79% | 64 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $28.24 | -0.85% | 52 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $390 → $400 | $442.36 | -9.58% | 49 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $550 | $552.06 | -0.37% | 52 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $60 → $65 | $67.61 | -3.86% | 44 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 | $155.54 | +28.58% | 33 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 | $221.56 | +12.84% | 54 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $13.11 | +128.83% | 12 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $4.36 | +14.68% | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $5.42 | +140.07% | 1 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 | $62.32 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $89.41 | n/a | 1 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $14 | $33.11 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.0001 | n/a | 1 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $1.17 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 → $75 | $76.90 | n/a | 3 | Mar 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $33 | $38.87 | n/a | 2 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $1.33 | n/a | 6 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $75 | $7.66 | n/a | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $5 | $0.0001 | n/a | 5 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 → $65 | $35.12 | n/a | 5 | Dec 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $8.5 | $3.57 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $5 | $0.027 | n/a | 2 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $13.96 | n/a | 1 | Jun 11, 2019 |
BioNTech SE
Aug 20, 2026
Maintained: Buy
Price Target: $140
Current: $113.12
Upside: +23.76%
Merck & Co.
Aug 19, 2026
Rated: Buy
Price Target: $150
Current: $152.20
Upside: -1.45%
AbbVie
Aug 17, 2026
Rated: Buy
Price Target: $295 → $300
Current: $265.97
Upside: +12.79%
Milestone Pharmaceuticals
Aug 13, 2026
Maintained: Buy
Price Target: $7
Current: $1.08
Upside: +548.15%
Regeneron Pharmaceuticals
Aug 12, 2026
Maintained: Hold
Price Target: $750
Current: $840.84
Upside: -10.80%
Vera Therapeutics
Aug 12, 2026
Rated: Buy
Price Target: $70
Current: $32.28
Upside: +116.89%
Mineralys Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $55
Current: $26.95
Upside: +104.08%
Jazz Pharmaceuticals
Aug 10, 2026
Maintained: Buy
Price Target: $300
Current: $252.16
Upside: +18.97%
BioMarin Pharmaceutical
Aug 7, 2026
Maintained: Buy
Price Target: $75 → $80
Current: $69.33
Upside: +15.39%
Halozyme Therapeutics
Aug 7, 2026
Rated: Hold
Price Target: $75 → $95
Current: $107.62
Upside: -11.73%
Aug 6, 2026
Maintained: Buy
Price Target: $65 → $80
Current: $65.96
Upside: +21.29%
Aug 5, 2026
Rated: Buy
Price Target: $1,280 → $1,330
Current: $1,280.34
Upside: +3.88%
Aug 5, 2026
Rated: Buy
Price Target: $165
Current: $147.60
Upside: +11.79%
Aug 5, 2026
Maintained: Hold
Price Target: $28
Current: $28.24
Upside: -0.85%
Aug 4, 2026
Rated: Hold
Price Target: $390 → $400
Current: $442.36
Upside: -9.58%
Aug 4, 2026
Rated: Buy
Price Target: $550
Current: $552.06
Upside: -0.37%
Jul 31, 2026
Rated: Hold
Price Target: $60 → $65
Current: $67.61
Upside: -3.86%
Jul 31, 2026
Rated: Buy
Price Target: $200
Current: $155.54
Upside: +28.58%
Jul 30, 2026
Maintained: Buy
Price Target: $250
Current: $221.56
Upside: +12.84%
Jul 27, 2026
Maintained: Buy
Price Target: $30
Current: $13.11
Upside: +128.83%
May 5, 2026
Maintained: Hold
Price Target: $5
Current: $4.36
Upside: +14.68%
Apr 1, 2026
Maintained: Buy
Price Target: $13
Current: $5.42
Upside: +140.07%
Aug 12, 2025
Maintained: Buy
Price Target: $47
Current: $62.32
Upside: n/a
Jul 2, 2021
Reiterated: Buy
Price Target: $95
Current: $89.41
Upside: n/a
Jun 29, 2021
Maintained: Buy
Price Target: $30 → $14
Current: $33.11
Upside: n/a
Jun 4, 2021
Initiated Coverage: Buy
Price Target: $3
Current: $0.0001
Upside: n/a
Apr 5, 2021
Initiated Coverage: Buy
Price Target: $52
Current: $1.17
Upside: n/a
Mar 26, 2021
Initiated Coverage: Buy
Price Target: $15 → $75
Current: $76.90
Upside: n/a
Mar 24, 2021
Maintained: Buy
Price Target: $20 → $33
Current: $38.87
Upside: n/a
Feb 25, 2021
Maintained: Buy
Price Target: $25 → $27
Current: $1.33
Upside: n/a
Jan 20, 2021
Maintained: Buy
Price Target: $36 → $75
Current: $7.66
Upside: n/a
Jan 5, 2021
Maintained: Buy
Price Target: $10 → $5
Current: $0.0001
Upside: n/a
Dec 23, 2020
Maintained: Buy
Price Target: $75 → $65
Current: $35.12
Upside: n/a
Sep 15, 2020
Maintained: Hold
Price Target: $11 → $8.5
Current: $3.57
Upside: n/a
Apr 27, 2020
Maintained: Buy
Price Target: $8 → $5
Current: $0.027
Upside: n/a
Jun 11, 2019
Initiated Coverage: Buy
Price Target: $21
Current: $13.96
Upside: n/a